Variable | Acute | Chronic | p-value | ||
---|---|---|---|---|---|
n | % | n | % | ||
526 | 60.5 | 343 | 39.5 | ||
Gender | |||||
Female | 213 | 40.5 | 157 | 45.8 | |
Male | 313 | 59.5 | 186 | 54.2 | .12 |
Race | |||||
African American | 119 | 22.6 | 64 | 18.7 | |
Asian | 12 | 2.3 | 4 | 1.2 | |
Asian/Pacific Islander | 1 | 0.2 | 2 | 0.6 | |
Biracial | 8 | 1.5 | 4 | 1.2 | |
Caucasian | 324 | 61.6 | 233 | 67.9 | |
Hispanic | 18 | 3.4 | 4 | 1.2 | |
Native American | 4 | 0.8 | 10 | 2.9 | |
Other | 28 | 5.3 | 15 | 4.4 | |
Unknown | 12 | 2.4 | 7 | 2.1 | .04 |
Age | |||||
Median(IQR) | 9.5 | (4.0–13.0) | 12.0 | 7.0–15.0 | 0.0004 |
Required Orthopedic Follow-up > 1 Year and < 2 Years (%) | 25 | 4.8 | 48 | 14.0 | < .0001 |
Region | |||||
Northeast | 33 | 6.3 | 28 | 8.2 | |
Midwest | 192 | 36.5 | 145 | 42.3 | |
South | 266 | 50.6 | 139 | 40.5 | |
West | 35 | 6.7 | 31 | 9.0 | .03 |
Time of year Of Diagnosis | |||||
Spring | 126 | 24.0 | 62 | 18.1 | |
Summer | 103 | 19.6 | 66 | 19.2 | |
Fall | 135 | 25.7 | 63 | 18.4 | |
Winter | 162 | 30.8 | 152 | 44.3 | .0003 |
Insurance Status | |||||
Medicaid | 171 | 32.5 | 113 | 32.9 | |
Private/HMO | 154 | 29.3 | 108 | 31.5 | |
Govt/Military | 34 | 6.5 | 17 | 5.0 | |
Self-pay | 20 | 3.8 | 8 | 2.3 | |
Not stated | 147 | 27.9 | 97 | 28.3 | 0.350 |
Pathogens Isolated* | |||||
MSSA | 51 | 6 | |||
MRSA | 41 | 13 | |||
S. aureus NOS | 33 | 10 | |||
Staphylococcus spp. | 29 | 15 | |||
S. pyogenes | 7 | 2 | |||
Salmonella spp. | 3 | 0 | |||
Pseudomonas spp. | 7 | 3 | |||
Serratia spp. | 1 | 2 | |||
Culture growth: | |||||
Blood culture | 61 | 48.8 | 7 | 21.2 | |
Bodily fluid (e.g.synovial fluid, abscess) | 5 | 4.0 | 3 | 9.1 | |
Wound/tissue culture (including bone/bone marrow) | 55 | 44.0 | 20 | 60.6 | |
Othera | 4 | 3.2 | 3 | 9.1 | 0.238 |